CSPC Pharmaceutical Group Limited (CVG) — Financial Flexibility Index
CSPC Pharmaceutical Group Limited (CVG) has a Financial Flexibility Index of 0.29x as of June 2020. Free cash flow of €2.41 Billion (operating CF €2.16 Billion minus capex €258.14 Million) represents 0% of total liabilities (€8.46 Billion). Check CVG cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CSPC Pharmaceutical Group Limited Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for CSPC Pharmaceutical Group Limited across 13 annual periods. For the full cash flow conversion analysis, see CVG cash flow conversion.
Annual Financial Flexibility Index for CSPC Pharmaceutical Group Limited (2013–2025)
Year-by-year free cash flow to debt coverage for CSPC Pharmaceutical Group Limited. Explore cash flow to debt ratio of CSPC Pharmaceutical Group Limited to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.67x | €8.11 Billion | €5.83 Billion | €12.15 Billion | ▼ -2.6% |
| 2024 | 0.69x | €7.21 Billion | €4.53 Billion | €10.52 Billion | ▲ +27.2% |
| 2023 | 0.54x | €6.07 Billion | €4.18 Billion | €11.26 Billion | ▼ -44.6% |
| 2022 | 0.97x | €9.85 Billion | €7.63 Billion | €10.13 Billion | ▲ +27.2% |
| 2021 | 0.76x | €6.05 Billion | €4.64 Billion | €7.91 Billion | ▼ -34.2% |
| 2020 | 1.16x | €8.10 Billion | €6.74 Billion | €6.97 Billion | ▲ +39.4% |
| 2019 | 0.83x | €5.67 Billion | €3.78 Billion | €6.80 Billion | ▲ +17.1% |
| 2018 | 0.71x | €5.46 Billion | €3.80 Billion | €7.67 Billion | ▼ -18.3% |
| 2017 | 0.87x | €4.47 Billion | €3.29 Billion | €5.13 Billion | ▼ -10.4% |
| 2016 | 0.97x | €3.98 Billion | €2.92 Billion | €4.09 Billion | ▲ +50.0% |
| 2015 | 0.65x | €3.06 Billion | €2.25 Billion | €4.73 Billion | ▲ +7.9% |
| 2014 | 0.60x | €2.61 Billion | €1.81 Billion | €4.35 Billion | ▲ +95.9% |
| 2013 | 0.31x | €1.41 Billion | €814.86 Million | €4.60 Billion | — |